12-09-2017 | Kaposi sarcoma | Article
This study finds that the absolute risk of non-AIDS-defining secondary cancers is higher in Kaposi sarcoma patients in the HAART era, yet the overall relative risk of secondary cancers has decreased.
Kumar V et al. Cancer Causes Control 2017; 28: 1065-1074. doi:10.1007/s10552-017-0957-0
25-08-2017 | Sarcoma | Article
In the largest study of extramedullary myeloid sarcoma in the US, the authors use the National Cancer Database to describe the clinical features, prognostic factors and early treatment outcomes.
Blood Cancer J 2017; 7: e592. doi:10.1038/bcj.2017.79
01-11-2016 | Sarcoma | Article
It is important for clinicians to be mindful of Kaposi’s sarcoma manifesting in a growing variety of clinical contexts. Here, Curtiss et al. provide an update on the epidemiology and treatment of this tumor.
Curtiss P, Strazzulla LC, & Friedman-Kien AE. Dermatol Ther (Heidelb) 2016;6:465–470. doi:10.1007/s13555-016-0152-3